36 reports

  • Genetic Testing Market: Revenue in USD million, Liquid Biopsy, by Country,
  • Genetic Testing Market: Revenue in USD million, Diagnostic Testing, by Type,

As of 2017, the global genetic testing market was valued at USD 9,367.0 million and is expected to record a CAGR of around 10.4% during 2018-2023 (the forecast period). In 2017, the North American genetic testing segment of the market studied accounted for the highest revenue and Asia-Pacific is expected to register the highest CAGR of 12.6%...

  • Biopsy
  • North America
  • United States
  • World
  • Forecast
  • 15.2 PERSONALIZED MEDICINE TO SPUR USE OF LIQUID BIOPSY TESTS IN
  • 3.3 GLOBAL LIQUID BIOPSY MARKET SHARE & FORECAST - BY APPLICATION

Other Fluids Sample ##.

  • Biopsy
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • 11.15.4 KEY DEVELOPMENTS
  • Date

Tel: + ##-##-##-## Fax: + ##-##-##-## Website: www. illumina. com ##. ##. ## OVERVIEW Illumina is one of the world leaders in sequencing and array based solutions for genetic analysis.

  • Biopsy
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

Chapter ##: Introduction Study Goals and Objectives BCC Research’s goal for this study is to provide an in-depth update study of the liquid biopsy diagnostics industry, an emerging industry with high market potential.

  • Biopsy
  • Diagnostics
  • World
  • Forecast
  • Market Size
  • OTHER PROMINENT VENDORS

It is a new entrant in the market, which develops liquid biopsy products based on genetic technology.

  • Biopsy
  • Biocept, Inc.
  • Exosome Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • CTDNA PLATFORMS FOR DETECTION OF EGFR MUTATIONS
  • LIQUID BIOPSY: INSIGHTS

Fig ## PARADIGM SHIFT: RX TO CDX Fig ## ## ## ## ## ## ## ADVANCEMENTINTHERAPYAREAS ANALYSIS Sense and Response Predict and Act?

  • Biopsy
  • North America
  • United States
  • World
  • Market Size

Moreover, unlike tissue biopsies, which are obtained from only one tumor region, a liquid biopsy can better reflect the genetic profile of all tumor sub-clones present in the patient.

  • Biopsy
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • MDxHealth SA
  • OPKO Health, Inc.
  • Advantages of Liquid Biopsy in Screening Market
  • ii. Guide for Executives, Marketing, Sales and Business Development Staff

From a genetic perspective, a tumor in another location, like your liver, may have a different genetic profile than the one that started in your lung.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • Advantages of Liquid Biopsy in Screening Market
  • ii. Guide for Executives, Marketing, Sales and Business Development Staff

From a genetic perspective, a tumor in another location, like your liver, may have a different genetic profile than the one that started in your lung.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • NEOGENOMICS
  • SELECTED LIQUID BIOPSY TESTS BASED ON EXTRACELLULAR VESICLES/OTHER ANALYTES, 2017

MOREOVER, THE DETECTION OF MUTATIONS ON CTDNA, ESPECIALLY THE RARE ONES, BECOMES HIGHLY DIFFICULT, SINCE GENETIC MUTATIONS OCCUR INFREQUENTLY AND APPEAR IRREGULARLY THROUGHOUT THE GENOME.

  • Biopsy
  • World
  • Epigenomics AG
  • QIAGEN N.V.
  • Roche Group
  • MARKET SIZE AND FORECAST
  • Market landscape

Develops liquid biopsy product based on genetic technology.

  • Biopsy
  • Biocept, Inc.
  • Exosome Diagnostics, Inc.
  • QIAGEN N.V.
  • Roche Group
  • ISET TEST
  • SELECTMDX

GENETIC TECHNOLOGIES ##.

  • Biopsy
  • North America
  • United States
  • Market Size
  • Biocept, Inc.
  • Diagnostic laboratories - Market size and forecast 2017-2022

You can easily book an appointment with one online.

  • Biopsy
  • United States
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.

Through the detection of different biomarkers, the diagnosis of cardiovascular diseases, infections, immunological and genetic disorders is certainly possible and opens new hopes for the patients.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

Excisional Biopsy ##.

  • Biopsy
  • United States
  • B. Braun Melsungen AG
  • Becton Property Group
  • Boston Scientific Corporation

Global Liquid Biopsy Figure ##.

  • Biopsy
  • Diagnostics
  • World
  • 2.2 United States - Liquid Biopsy Screening Potential Market
  • United States - Liquid Biopsy Potential Market (Million US$), 2015 - 2020

Liquid Biopsy Market - Major Deals Analysis ##.

  • Biopsy
  • Diagnostics
  • United States
  • Forecast
  • Biocept, Inc.

Strategic Initiatives List of Table Table ##.

  • Biopsy
  • Diagnostics
  • United States
  • Market Size
  • Dec 05, 2017: First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform
  • SEP 09, 2016: BIOCEPT TO COLLABORATE WITH RENOWNED CLINICAL INVESTIGATOR DR. SHILPA GUPTA TO STUDY THE UTILITY OF LIQUID BIOPSY TESTING IN BLADDER AND PROSTATE CANCERS

Biocept will develop and commercialize one or more tests.

  • Biopsy
  • Medical Device
  • United States
  • Company
  • Biocept, Inc.
  • Deal Type

Billable accessions for the fourth quarter of 2017 reflected one less sales day versus the fourth quarter of 2016.

  • Biopsy
  • Cancer
  • Healthcare
  • United States
  • Biocept, Inc.
  • Function

Genetic Disorder ## Lung Cancer ## Melanoma ## Metastatic Breast Cancer ## Non-Small Cell Lung Cancer ## Prostate Cancer ## Small Cell Lung Cancer ## Indication No of Products Biocept Inc - Pipeline Analysis Overview BIOCEPT INC - KEY

  • Biopsy
  • Clinical Trial
  • United States
  • Company
  • Biocept, Inc.
  • LIQUID BIOPSY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND
  • TROVAGENE INC.: COMPANY SNAPSHOT (2016)

(US), raised funds worth USD ## billion, with Tencent (China) being one of its investors.

  • Biopsy
  • North America
  • United States
  • Forecast
  • Market Size
  • INIVATA LTD, RECENT DEVELOPMENTS

Notes Recent Development section covers news posted during last one year GlobalData considers regulatory approved (Approved and Issued) products as pipeline in case products are yet to launch in the market.

  • Biopsy
  • Clinical Trial
  • Lung Cancer
  • Specialty Hospital
  • Inivata Limited
  • GLOBAL BIOPSY DEVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • KEY FINDINGS

IN ADDITION, THIS TECHNIQUE AIDS IN CAPTURING THE ENTIRE GENETIC COMPLEXITY OF TUMORS AND HELPS IN LIMITING THE CHANCES OF CANCER CELLS SPREADING TO OTHER BODY PARTS.

  • Biopsy
  • North America
  • United States
  • Forecast
  • Becton Property Group
  • ISOFLUX CTC LIQUID BIOPSY SYSTEM - COLON CANCER - PRODUCT STATUS
  • ISOFLUX CTC LIQUID BIOPSY SYSTEM - LUNG CANCER - PRODUCT STATUS

Fluxion has made a significant improvement with their ERASE-Seq software to break through that sensitivity barrier, getting down to the ##. ##% threshold, which puts NGS on par with many other genetic tools.

  • Biopsy
  • Cancer
  • Diagnostics
  • United States
  • Product Initiative
  • IVLCM CAPSULE - PRODUCT DESCRIPTION

One unit refers to one Biopsy Forceps.

  • Biopsy
  • Clinical Trial
  • Hospital
  • Medical Device
  • GlobalData's company

FH IS ONE OF ## GENETIC CONDITIONS BEING TARGETED IN GEISINGER S MYCODE COMMUNITY HEALTH INITIATIVE.

  • Biopsy
  • Body Contouring Device
  • North America
  • United States
  • Forecast

Researchers used ultrasound to mechanically perturb T cells, and then converted the mechanical signals into genetic control of cells.

  • Biopsy
  • Diagnostic Imaging
  • Ultrasound
  • United States
  • Company